Novavax announced on Monday that it will conduct phase two clinical trials to determine whether its coronavirus vaccine candidate has positive effects for patients.
The Maryland-based company is one of many companies around the world that are running for an outbreak of COVID-19, the disease caused by the new coronavirus. His resolution to start the testing phase comes a few weeks after reporting that his Vaccine showed promising symptoms in early trials.
Phase two trials will be conducted in South Africa, one of the countries with the maximum number of severe outbreaks amid the pandemic.As of Monday, the country had reported more than 587,000 cases shown of COVID-19 and about 11,800 COVID-19 deaths, according to a Johns Hopkins University database.
Gregory Glenn, president of Studies and Progression for Novavax, mentioned the effect of the virus in South Africa in relation to phase two trials.
“Because South Africa is experiencing a winter outbreak of COVID-19 disease, this Phase 2b clinical trial has the potential to provide an early indication of efficacy as well as more protection and immunogenicity data,” he said.
Shabir Madhi, who will lead the trials, added that “the main motivation for early-stage COVID-19 vaccines in South Africa is to generate in the African context about the effectiveness of these vaccines in contexts like ours.”
Phase one trials for the candidate vaccine produced “strong antibody responses,” Novavax said in early August.The company said tests showed that other people who won the vaccine had higher levels of antibodies than others who had already recovered from coronavirus.
Each player in the first trial that won the candidate vaccine produced antibodies, Novavax said.
Phase two assay will compare its efficacy, protection and immunogenicity in more than 2,600 healthy adults.It will also compare protection for a large number of medically stable HIV-positive adults, the company added.
Novavax won a $15 million grant from the Bill Foundation
More than a hundred vaccines imaginable are being developed around the world.Companies such as Moderna, AstraZeneca and Pfizer have developed applicants who have lately been in the three-trial phase.
Russia announced last week that a coronavirus vaccine was in a position to be used in the country, but that phase 3 trials of the drug would not be completed.The right thing today ”The FDA leader says he supports accelerating the coronavirus vaccine if ”Lara Trump’s Lack of Distance” Is Right: We inspire others to stick to more rules Fix the biggest infectious disease The U.S. specialist, said he doubts “seriously” that the Russian vaccine has proven to be safe and effective.
Look at the thread.
The Hill 1625 K Street, NW Suite 900 Washington DC 20006202-628-8500 tel.202-628-8503 fax
The content of this is © 2020 Capitol Hill Publishing Corp., a subsidiary of News Communications, Inc.